Solar stocks ticked higher as yields fell. The Inv
Post# of 27112
climbed more than 8.1%, with constituents SunRun
and Enphase
gaining 20% and 12%, respectively. Shares of Moderna
climbed 9.3% after trial data showed its experimental cancer vaccine reduced the risk of death or reoccurrence when used alongside Merck’s Keytruda.